APA

Langley R. G., Elewski B. E., Lebwohl M., Reich K., Griffiths C. E. M., Papp K., Puig L., Nakagawa H., Spelman L., Sigurgeirsson B., Rivas E., Tsai T., Wasel N., Tyring S., Salko T., Hampele I., Notter M., Karpov A., Helou S. & Papavassilis C. (20140729). Secukinumab in plaque psoriasis--results of two phase 3 trials. : The New England journal of medicine.

Chicago

Langley Richard G, Elewski Boni E, Lebwohl Mark, Reich Kristian, Griffiths Christopher E M, Papp Kim, Puig Lluís, Nakagawa Hidemi, Spelman Lynda, Sigurgeirsson Bárður, Rivas Enrique, Tsai Tsen-Fang, Wasel Norman, Tyring Stephen, Salko Thomas, Hampele Isabelle, Notter Marianne, Karpov Alexander, Helou Silvia and Papavassilis Charis. 20140729. Secukinumab in plaque psoriasis--results of two phase 3 trials. : The New England journal of medicine.

Harvard

Langley R. G., Elewski B. E., Lebwohl M., Reich K., Griffiths C. E. M., Papp K., Puig L., Nakagawa H., Spelman L., Sigurgeirsson B., Rivas E., Tsai T., Wasel N., Tyring S., Salko T., Hampele I., Notter M., Karpov A., Helou S. and Papavassilis C. (20140729). Secukinumab in plaque psoriasis--results of two phase 3 trials. : The New England journal of medicine.

MLA

Langley Richard G, Elewski Boni E, Lebwohl Mark, Reich Kristian, Griffiths Christopher E M, Papp Kim, Puig Lluís, Nakagawa Hidemi, Spelman Lynda, Sigurgeirsson Bárður, Rivas Enrique, Tsai Tsen-Fang, Wasel Norman, Tyring Stephen, Salko Thomas, Hampele Isabelle, Notter Marianne, Karpov Alexander, Helou Silvia and Papavassilis Charis. Secukinumab in plaque psoriasis--results of two phase 3 trials. : The New England journal of medicine. 20140729.